Navigation Links
Dilon Diagnostics Receives ISO 13485 Certification
Date:3/2/2010

NEWPORT NEWS, Va., March 2 /PRNewswire/ -- Dilon Diagnostics, a manufacturer and supplier of high-resolution molecular imaging systems, announced today that it has received ISO 13485 certification. The certification confirms Dilon's commitment to continual improvement of products, customer satisfaction, compliance with statutory and regulatory requirements and risk management.

ISO 13485 is an internationally recognized standard system which defines the requirements for design, development, production, and distribution of medical devices. It ensures conformity with specified quality controls in the development of safe and effective medical devices.

The Dilon 6800 Gamma Camera, Dilon's cornerstone product, is a high-resolution, small field-of-view gamma camera optimized to perform Breast-Specific Gamma Imaging (BSGI). BSGI is a molecular breast imaging procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. The Dilon 6800 captures vital information by viewing the metabolic activity in the breast; it can identify lesions independent of tissue density and is capable of duplicating standard mammographic views. In addition the Dilon GammaLoc™ system, an accessory to the Dilon 6800®, is the only FDA-cleared localization device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with BSGI.

Dilon's recent distribution agreement with Philips, allows the renowned healthcare company to sell and support the Dilon products in European and key Middle Eastern markets. The partnership with the global leader in medical technology demonstrates the significant endorsement of MBI/BSGI and its continued commitment to deliver the most advanced women's health solutions worldwide.

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

SOURCE Dilon Diagnostics

Back to top

RELATED LINKS
http://www.dilon.com

'/>"/>

SOURCE Dilon Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
2. Quest Diagnostics Unveils Care360(TM) EHR
3. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
4. Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
5. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
6. Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.
7. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
8. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
9. Fujirebio Diagnostics Named Life Sciences Company of the Year
10. U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology
11. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... ), a developer of a new generation of ... positive overall survival results for Paclical/Apealea in the ... 789 patients with epithelial ovarian cancer. These preliminary ... Paclical/Apealea in combination with carboplatin versus Taxol in ...
(Date:4/27/2016)... , April 27, 2016 At ... the launch of a Phase 2 clinical study of ... in patients undergoing cochlear implantation (CI) surgery. This large, ... in Germany and ... middle ear at the time of surgery. "Despite advances ...
(Date:4/26/2016)... , April 26, 2016 US ... forecast to expand 4.9 percent annually to $27.6 ... other healthcare facilities to decrease rates of healthcare-associated ... prevention supplies, equipment, and services.  Although declining, the ... significantly above targeted levels set by the CDC.  ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... ... on April 4th, 2016 questioned the use of the HyProCure sinus tarsi ... “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, ...
(Date:4/29/2016)... , ... April 30, 2016 , ... Mercy College is ... The following programs will be expanding due to high demand: Master of Business ... expansion will begin this summer. , School of Business Graduate Program Chair ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic ... the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain ... mood optimization products to the store is just one more way Shamangelic Healing ...
(Date:4/29/2016)... Torrance, CA (PRWEB) , ... April 29, 2016 ... ... physician advocating optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and ... Talk Radio Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie ...
(Date:4/29/2016)... ... April 29, 2016 , ... A new study ... severe congenital diaphragmatic hernia have better survival rates if surgery is performed early. ... condition where the diaphragm fails to form completely, letting abdominal organs into the ...
Breaking Medicine News(10 mins):